Anti-dsDNA antibodies are typically associated with lupus nephritis, a condition that does not align with the patient's pulmonary symptoms.

Anti-centromere antibodies are associated with limited scleroderma (CREST syndrome), which predominantly affects the skin and has a lesser involvement of internal organs like lungs.

Anti-smooth muscle antibodies are characteristic of autoimmune hepatitis, which is not consistent with the patient's findings.

Anti-Scl-70, also known as anti-topoisomerase I, is the most commonly associated autoantibody in patients with systemic sclerosis (scleroderma), which can present with interstitial lung disease. This correlates well with the patient's symptoms including fatigue, low-grade fever, bilateral interstitial lung changes, and restrictive lung disease resulting from fibrosis.